Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
通过减少核苷酸诱导的炎症来恢复唾液腺功能
基本信息
- 批准号:8630757
- 负责人:
- 金额:$ 59.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-17 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:ATP ReceptorsAdverse effectsAffectAffinityAmericanApoptosisApoptoticBacterial InfectionsBiological MarkersCationsCell DeathCell surfaceCellsCellular MorphologyChemicalsChronicChronic DiseaseClinical TreatmentClinical TrialsDiseaseDuct (organ) structureEpithelial CellsEpitheliumEtiologyEventFibrosisFunctional disorderGlandGoalsHead and Neck CancerHealthHumanInfiltrationInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseLigandsLigationLungLymphocyteModelingMusNerve DegenerationNeutrophil InfiltrationNucleotidesOralPlayProcessProductionQuality of lifeRadiationRadiation induced damageReceptor ActivationReceptor SignalingResearchRheumatoid ArthritisRoleSalivaSalivarySalivary Gland TissueSalivary GlandsSignal PathwaySjogren&aposs SyndromeSpinal cord injuryStressSubmandibular glandTherapeuticTimeTissuesTraumaWild Type MouseWorkXerostomiaautoimmune exocrinopathybaseextracellularfunctional restorationin vivoin vivo Modelinjuredloss of functionmouse modelnutritionpreventreceptorreceptor functionresponsesaliva secretiontumor growth
项目摘要
DESCRIPTION (provided by applicant): Salivary gland dysfunction affects millions of Americans whose quality of life is severely impacted by dry mouth, oral bacterial infections, poor nutrition, and other disorders that are associated with decreased saliva production. Loss of saliva production is most common in Sjögren's syndrome (SS), an autoimmune exocrinopathy of unknown etiology in which decreased saliva production is followed by lymphocytic infiltration of the salivary gland and ultimately tissue degeneration. In addition, salivary gland inflammation and hyposalivation is an unintended side effect of γ-radiation used for the treatment of head and neck cancers. Understanding the mechanisms underlying early events in salivary gland inflammation will help identify currently-unavailable therapeutic options to treat salivary gland degeneration. It is now well recognized that high levels of intracellular nucleotides, particularly
ATP, are released from cells under pathological conditions in response to inflammation, stress or trauma. Our research has focused on understanding the ATP- dependent mechanisms involved in salivary gland inflammation and degeneration. Recent work by our group indicates that salivary gland inflammation can be initiated by activation of the P2X7 receptor (P2X7R), an ATP- gated, non-selective cation channel that also promotes inflammation and cell apoptosis in several chronic diseases, including rheumatoid arthritis, lung fibrosis, and neurodegenerative and inflammatory bowel diseases. Preliminary studies presented in this proposal indicate that neutrophil recruitment to duct-ligated submandibular gland (SMG) is significantly reduced in P2X7R-/- mice compared to control mice when the glands were perfused with BzATP, a high affinity P2X7R ligand that we initially developed. Therefore, we will utilize primary isolated salivary gland cells and the duct ligation model of salivary gland inflammation in wild type and P2X7R-/- mice to elucidate whether inflammatory responses associated with the P2X7R play a significant role in functional SMG degeneration and the mechanisms involved (Specific Aim 1). Other studies will extend these results to mouse models of radiation-induced salivary gland damage (Specific Aim 2) and autoimmune exocrinopathy (Specific Aim 3), where the availability of the P2X7R-/- mouse and P2X7R-selective antagonists (currently in clinical trials for the treatment of rheumatoid arthritis and spinal cord injury) will enable us to directly examine whether decreases in P2X7R function in vivo can retard salivary gland degeneration. Thus, the overall goal of these studies is to evaluate whether inhibition of P2X7R activity can protect the salivary gland from various forms of tissue damage in mice, which ultimately will be essential for developing treatments for human salivary dysfunction.
描述(申请人提供):唾液腺功能障碍影响数以百万计的美国人,他们的生活质量受到口腔干燥、口腔细菌感染、营养不良和其他与唾液产生减少相关的疾病的严重影响。唾液分泌减少在干燥综合征(SS)中最为常见,这是一种病因不明的自身免疫性外分泌病,唾液分泌减少后,唾液腺中的淋巴细胞渗入,最终导致组织变性。此外,唾液腺发炎和唾液腺萎缩是γ辐射用于治疗头颈癌的一种意外副作用。了解唾液腺炎症早期事件的机制将有助于确定目前无法治疗唾液腺退化的治疗方案。现在人们已经很好地认识到,细胞内高水平的核苷酸,特别是
三磷酸腺苷是细胞在病理条件下对炎症、应激或创伤做出的反应。我们的研究侧重于了解唾液腺炎症和退化所涉及的ATP依赖机制。我们团队最近的工作表明,唾液腺炎症可以通过激活P2X7受体(P2X7R)来启动,P2X7R是一种ATP门控的非选择性阳离子通道,也可以促进几种慢性疾病的炎症和细胞凋亡,包括类风湿性关节炎、肺纤维化以及神经退行性和炎症性肠病。这项建议中提出的初步研究表明,当我们最初开发的一种高亲和力的P2X7R配体BzATP灌流到P2X7R-/-小鼠的颌下腺(SMG)时,与对照组小鼠相比,中性粒细胞向颌下腺(SMG)的募集显著减少。因此,我们将利用原代分离的唾液腺细胞和野生型和P2X7R-/-小鼠唾液腺炎症的导管结扎模型来阐明与P2X7R相关的炎症反应是否在功能性SMG变性中发挥重要作用及其相关机制(特定目标1)。其他研究将把这些结果扩展到辐射诱导的唾液腺损伤(特异性目标2)和自身免疫性外分泌病(特异性目标3)的小鼠模型,其中P2X7R-/-小鼠和P2X7R选择性拮抗剂的可用性(目前处于治疗类风湿性关节炎和脊髓损伤的临床试验中)将使我们能够直接检查体内P2X7R功能的降低是否可以延缓唾液腺退化。因此,这些研究的总体目标是评估抑制P2X7R活性是否可以保护小鼠的唾液腺免受各种形式的组织损伤,这最终将是开发治疗人类唾液功能障碍的关键。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY Andrew WEISMAN其他文献
GARY Andrew WEISMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY Andrew WEISMAN', 18)}}的其他基金
The P2X7 receptor for ATP as a therapeutic target in the prevention of radiation-induced salivary gland dysfunction
ATP 的 P2X7 受体作为预防辐射引起的唾液腺功能障碍的治疗靶点
- 批准号:
10659723 - 财政年份:2023
- 资助金额:
$ 59.06万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10685136 - 财政年份:2022
- 资助金额:
$ 59.06万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10554383 - 财政年份:2021
- 资助金额:
$ 59.06万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10360664 - 财政年份:2021
- 资助金额:
$ 59.06万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10788973 - 财政年份:2021
- 资助金额:
$ 59.06万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10219752 - 财政年份:2021
- 资助金额:
$ 59.06万 - 项目类别:
2017 Salivary Glands and Exocrine Biology Gordon Research Conference & Gordon Research Seminar
2017年唾液腺与外分泌生物学戈登研究会议
- 批准号:
9248729 - 财政年份:2016
- 资助金额:
$ 59.06万 - 项目类别:
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
通过减少核苷酸诱导的炎症来恢复唾液腺功能
- 批准号:
9185314 - 财政年份:2013
- 资助金额:
$ 59.06万 - 项目类别:
The Regulation of Salivary Gland Regeneration by P2Y2 Nucleotide Receptors
P2Y2核苷酸受体对唾液腺再生的调控
- 批准号:
7932509 - 财政年份:2009
- 资助金额:
$ 59.06万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 59.06万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 59.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 59.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 59.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 59.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 59.06万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 59.06万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 59.06万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 59.06万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 59.06万 - 项目类别:
Studentship